S
FUSN

SignatureFD’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

SignatureFD’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,949
Closed -$62.9K – 3288
2024
Q1 		$62.9K Hold
2,949
– – ﹤0.01% 1424
2023
Q4 		$28.3K Buy
2,949
+2,649
+883% +$12.9K ﹤0.01% 1749
2023
Q3 		$789 Hold
300
– – ﹤0.01% 2965
2023
Q2 		$1.4K Hold
300
– – ﹤0.01% 2899
2023
Q1 		$1.13K Hold
300
– – ﹤0.01% 2957
2022
Q4 		$945 Hold
300
– – ﹤0.01% 2988
2022
Q3 		$1K Hold
300
– – ﹤0.01% 3068
2022
Q2 		$1K Hold
300
– – ﹤0.01% 3052
2022
Q1 		$2K Hold
300
– – ﹤0.01% 2892
2021
Q4 		$1K Hold
300
– – ﹤0.01% 3037
2021
Q3 		$2K Hold
300
– – ﹤0.01% 2734
2021
Q2 		$2K Hold
300
– – ﹤0.01% 2641
2021
Q1 		$3K Hold
300
– – ﹤0.01% 2402
2020
Q4 		$4K Hold
300
– – ﹤0.01% 2080
2020
Q3 		$4K Hold
300
– – ﹤0.01% 2019
2020
Q2 		$5K Buy
+300
New +$5.22K ﹤0.01% 1843

SignatureFD's FUSN Position: Q2 2024 in Review

SignatureFD sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 2,949 shares — an estimated $62.9K sold.

SignatureFD first reported a position in FUSN in Q2 2020 and held it in 16 quarters. The position peaked at $62.9K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

  • SignatureFD reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
  • SignatureFD sold 2,949 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $62.9K.
  • SignatureFD first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 16 quarters.
  • SignatureFD's Fusion Pharmaceuticals Inc. Common Shares position peaked at $62.9K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on SignatureFD's 13F filing for Q2 2024, filed 29 Jul 2024.